Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing's sarcoma A673-xenograft growth and normalize tumor vascular architecture (Q39292783)

10 September 2017

title

Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing's sarcoma A673-xenograft growth and normalize tumor vascular architecture (English)

1 reference

10 September 2017

1 reference

Maximilian Ackermann

1

1 reference

10 September 2017

Brent A Morse

2

1 reference

10 September 2017

Vera Delventhal

3

1 reference

10 September 2017

Irvith M Carvajal

4

1 reference

10 September 2017

Moritz A Konerding

5

1 reference

10 September 2017

publication date

23 August 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

15

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

685-695

1 reference

Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Ewing's sarcoma: standard and experimental treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Phase I and pharmacokinetic study of CT-322 (BMS-844203), a targeted Adnectin inhibitor of VEGFR-2 based on a domain of human fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

The role of IGF-1R in pediatric malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Practical stereological methods for morphometric cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Computational flow dynamics in a geometric model of intussusceptive angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

sFLT01: a novel fusion protein with antiangiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Vascular endothelial growth factor: a therapeutic target for tumors of the Ewing's sarcoma family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Inflammation-induced intussusceptive angiogenesis in murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

The effects of PTK787/ZK222584, an inhibitor of VEGFR and PDGFRβ pathways, on intussusceptive angiogenesis and glomerular recovery from Thy1.1 nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-012-9294-9

10.1007/S10456-012-9294-9

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference